Descriptive analysis of the economic burden of treatment resistance in a major depressive episode

References

• World Health Organization [Internet]. Media center fact sheet. Depression [updated 2017 Feb; cited 2017 Aug 25]. Available from: http://www.who.int/mediacentre/factsheets/fs369/en
   Google Scholar
• Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiat. 2018;75(4):336–346.
   PubMed Web of Science ®Google Scholar
• Coryell W, Young EA. Clinical predictors of suicide in primary major depressive disorder. J Clin Psychiat. 2005;66(4):412–417.
   PubMed Web of Science ®Google Scholar
• Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing chronic disease: Public health research, practice and policy. Prev Chronic Dis. 2006;3(2):A42.
   PubMedGoogle Scholar
• Cuijpers P, Smit F. Excess mortality in depression: a meta-analysis of community studies. J Affect Disorders. 2002;2(3):227–236.
   Web of Science ®Google Scholar
• Vos T, Flaxman MN, Lozano R, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163–2196.
   PubMed Web of Science ®Google Scholar
• Greenberg PE, Fournier AA, Sisitsky T, et al. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiat. 2015;76(02):155–162.
   PubMed Web of Science ®Google Scholar
• Rush J, Trivedi M, Wisniewski S, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiat. 2006;163(11):1905–1917.
   PubMed Web of Science ®Google Scholar
• Souery D, Amsterdam J, de Montigny C, et al. Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharm. 1999;9(1–2):83–91.
   PubMed Web of Science ®Google Scholar
• Kubitz N, Mehra M, Potluri RC, et al. Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims database. PLoS One. 2013;8(10):e76882.
   PubMed Web of Science ®Google Scholar
• Gruber AJ, Hudson JI, Pope HG Jr. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder. Psychiatr Clin North Am. 1996;19(2):351–369.
   PubMed Web of Science ®Google Scholar
• Franco-Bronson K. The management of treatment-resistant depression in the medically ill. Psychiatr Clin North Am. 1996;19(2):329–350.
   PubMed Web of Science ®Google Scholar
• Al-Harbi KS. Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adher. 2012;6:369–388.
   PubMed Web of Science ®Google Scholar
• Russell JM, Hawkins K, Ozminkowski RJ, et al. The cost consequences of treatment-resistant depression. J Clin Psychiatry. 2004;65(3):341–347.
   PubMed Web of Science ®Google Scholar
• Mrazek DA, Hornberger JC, Altar CA, et al. A review of the clinical, economic, and societal burden of treatment-resistant depression. PS. 2014;65(8):977–987.
   Google Scholar
• McCusker J, Latimer E, Cole M, et al. Major depression among medically ill elders contributes to sustained poor mental health in their informal caregivers. Age Ageing. 2007;36(4):400–406.
   PubMed Web of Science ®Google Scholar
• Rane LJ, Fekadu A, Papadopoulos AS, et al. Psychological and physiological effects of caring for patients with treatment-resistant depression. Psychol Med. 2012;42(9):1825–1833.
   PubMed Web of Science ®Google Scholar
• Chang CC, Yen CF, Jang FL, et al. Comparing affiliate stigma between family caregivers of people with different severe mental illness in Taiwan. J Nerv Ment Dis. 2017;205(7):542–549.
   PubMed Web of Science ®Google Scholar
• Albert SM, Schulz R, Colombi A [Internet]. The MetLife Study of working caregivers and employer health care costs: case study. New insights and innovations for reducing health care costs for employers. 2010 [cited 2018 Apr 5]. Available from: http://www.caregiving.org/data/Caregiver_Costs_Study_Web_FINAL_2-12-10.pdf
   Google Scholar
• Olchanski N, McInnis MM, Halseth M, et al. The economic burden of treatment-resistant depression. Clin Ther. 2013;35(4):512–522.
   PubMed Web of Science ®Google Scholar
• Gaynes BN, Asher G, Gartlehner G, et al [Internet]. Definition of treatment-resistant depression in the Medicare population. Technology Assessment Program. Rockville, MD: Agency for Healthcare Research and Quality; 2018 [cited 2018 May 18]. Available from: https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id105TA.pdf
   Google Scholar
• US Food and Drug Administration [Internet]. Major depressive disorder: developing drugs for treatment. Guidance for industry. 2018 [cited 2018 Jul 17]. Available from: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM611259.pdf
   Google Scholar
• Amos T, Tandon N, Lefebvre P, et al. Direct and indirect cost burden and change of employment status in treatment-resistant depression: a matched-cohort study using a US commercial claims database. J Clin Psychiatry. 2018;79(2):pii: 17m11725.
   Web of Science ®Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139.
   PubMed Web of Science ®Google Scholar
• Corey-Lisle PK, Birnbaum HG, Greenberg PE, et al. Identification of a claims data “signature” and economic consequences for treatment-resistant depression. J Clin Psychiatry. 2002;63(8):717–726.
   PubMed Web of Science ®Google Scholar
• Sheehan J, Cai Q, Wu B, et al. Real-world economic burden associated with treatment-resistant depression. Poster presented at: ASHP Summer Meetings and Exhibition; 2018 Jun 2–6; Denver, CO.
   Google Scholar
• Ivanova JI, Birnbaum HG, Kidolezi Y, et al. Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder. Curr Med Res Opin. 2010;26(10):2475–2484.
   PubMed Web of Science ®Google Scholar
• Sussman M, O’sullivan AK, Shah A, et al. Economic burden of treatment-resistant depression on the U.S. health care system. JMCP. 2019;25:823–835.
   PubMed Web of Science ®Google Scholar
• Sheehan DV. Depression: underdiagnosed, undertreated, underappreciated. Manag Care. 2004;13(6 Suppl Depression):6–8.
   PubMedGoogle Scholar